# Kuvan®'s Effect on the Cognition of Children With Phenylketonuria

> **NCT01965912** · PHASE4 · COMPLETED · sponsor: **BioMarin Pharmaceutical** · enrollment: 34 (actual)

## Conditions studied

- Phenylketonuria

## Interventions

- **DRUG:** Kuvan®

## Key facts

- **NCT ID:** NCT01965912
- **Lead sponsor:** BioMarin Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965912, "Kuvan®'s Effect on the Cognition of Children With Phenylketonuria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01965912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*